T2 Biosystems
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 113
- Market Cap
- -
- Introduction
T2 Biosystems, Inc. is a vitro diagnostics company, which engages in the development of detection of sepsis-causing pathogens. It offers T2Dx instrument, T2Bacteria, T2Candida, T2Biothreat panels, and T2MR technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.
T2Resistance - Detection of Resistance Related Genes
- Conditions
- Resistance Bacterial
- Interventions
- Diagnostic Test: T2Resistance Panel
- First Posted Date
- 2022-02-09
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- T2 Biosystems
- Target Recruit Count
- 1566
- Registration Number
- NCT05231187
- Locations
- 🇺🇸
University of Texas Health Science Center, Houston, Texas, United States
🇺🇸University of Pittsburgh, Pittsburgh, Pennsylvania, United States
🇺🇸New York University Langone Health, Brooklyn, New York, United States
Detection of Borrelia Bacteria in Early Stage Lyme Borreliosis Using the T2Lyme Panel
- Conditions
- Lyme Disease
- Interventions
- Device: T2Lyme Panel testing
- First Posted Date
- 2018-07-10
- Last Posted Date
- 2022-02-04
- Lead Sponsor
- T2 Biosystems
- Target Recruit Count
- 18
- Registration Number
- NCT03581279
- Locations
- 🇺🇸
Gundersen Health System, La Crosse, Wisconsin, United States
🇺🇸South County Internal Medicine, Wakefield, Rhode Island, United States
T2Bacteria Panel Pivotal Study
- Conditions
- Bacteremia
- First Posted Date
- 2015-08-28
- Last Posted Date
- 2018-08-17
- Lead Sponsor
- T2 Biosystems
- Target Recruit Count
- 2430
- Registration Number
- NCT02535468
- Locations
- 🇺🇸
Henry Ford Health System, Detroit, Michigan, United States
🇺🇸University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
🇺🇸Rhode Island Hospital, Providence, Rhode Island, United States
Serial Therapeutic and Antifungal Monitoring Protocol
- Conditions
- Candidemia
- First Posted Date
- 2014-06-16
- Last Posted Date
- 2018-08-20
- Lead Sponsor
- T2 Biosystems
- Target Recruit Count
- 31
- Registration Number
- NCT02163889
- Locations
- 🇺🇸
University of Pittsburgh, Pittsburgh, Pennsylvania, United States
🇺🇸University of Alabama, Birmingham, Alabama, United States
🇺🇸Rhode Island Hospital, Providence, Rhode Island, United States
Detecting Infections Rapidly and Easily for Bacteremia Trial (DIREBT)
- Conditions
- Bacteremia
- First Posted Date
- 2013-08-09
- Last Posted Date
- 2015-09-28
- Lead Sponsor
- T2 Biosystems
- Target Recruit Count
- 156
- Registration Number
- NCT01919762
- Locations
- 🇺🇸
Cooper Medical School, Camden, New Jersey, United States
Detecting Infections Rapidly and Easily for Candidemia Trial - Part 2 (direcT2 Study)
- Conditions
- Candidemia
- First Posted Date
- 2012-12-19
- Last Posted Date
- 2014-05-26
- Lead Sponsor
- T2 Biosystems
- Target Recruit Count
- 1500
- Registration Number
- NCT01752166
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Henry Ford Health System, Detroit, Michigan, United States
🇺🇸University of Houston College of Pharmacy, Houston, Texas, United States
Detecting Infections Rapidly and Easily for Candidemia Trial (DIRECT)
- Conditions
- Candidemia
- First Posted Date
- 2012-02-02
- Last Posted Date
- 2014-06-09
- Lead Sponsor
- T2 Biosystems
- Target Recruit Count
- 700
- Registration Number
- NCT01525095
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸University of California San Francisco, San Francisco, California, United States
🇺🇸University of Kentucky, Lexington, Kentucky, United States